• STJ73584 (1µg/ml) staining of Human Amygdala (A) and Cerebellum (B) lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.

Anti-JIP1/MAPK8IP1 antibody (265-279) (STJ73584)

SKU:
STJ73584-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human/Mouse/Rat/Dog/Pig
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-JIP1/MAPK8IP1 (265-279) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.3-1µg/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: MAPK8IP1
Gene ID: 9479
Uniprot ID: JIP1_HUMAN
Immunogen Region: 265-279
Accession Number: NP_005447.1
Immunogen Sequence: DRIHYQADVRLEATE
Post Translational Modifications Phosphorylated by MAPK8, MAPK9 and MAPK10. Phosphorylation on Thr-103 is also necessary for the dissociation and activation of MAP3K12. Phosphorylated by isoform 1 and isoform 2 of VRK2. Hyperphosphorylated during mitosis following activation of stress-activated and MAP kinases. Ubiquitinated. Two preliminary events are required to prime for ubiquitination.phosphorylation and an increased in intracellular calcium concentration. Then, the calcium influx initiates ubiquitination and degradation by the ubiquitin-proteasome pathway.
Function The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Required for JNK activation in response to excitotoxic stress. Cytoplasmic MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK in the cytoplasm and inhibiting JNK phosphorylation of c-Jun. May also participate in ApoER2-specific reelin signaling. Directly, or indirectly, regulates GLUT2 gene expression and beta-cell function. Appears to have a role in cell signaling in mature and developing nerve terminals. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins. Functions as an anti-apoptotic protein and whose level seems to influence the beta-cell death or survival response. Acts as a scaffold protein that coordinates with SH3RF1 in organizing different components of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a functional multiprotein complex to ensure the effective activation of the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and differentiation of CD8(+) T-cells.
Protein Name C-Jun-Amino-Terminal Kinase-Interacting Protein 1
Jip-1
Jnk-Interacting Protein 1
Islet-Brain 1
Ib-1
Jnk Map Kinase Scaffold Protein 1
Mitogen-Activated Protein Kinase 8-Interacting Protein 1
Cellular Localisation Cytoplasm
Perinuclear Region
Nucleus
Endoplasmic Reticulum Membrane
Mitochondrion Membrane
Accumulates In Cell Surface Projections
Under Certain Stress Conditions
Translocates To The Perinuclear Region Of Neurons
In Insulin-Secreting Cells
Detected In Both The Cytoplasm And Nucleus
Alternative Antibody Names Anti-C-Jun-Amino-Terminal Kinase-Interacting Protein 1 antibody
Anti-Jip-1 antibody
Anti-Jnk-Interacting Protein 1 antibody
Anti-Islet-Brain 1 antibody
Anti-Ib-1 antibody
Anti-Jnk Map Kinase Scaffold Protein 1 antibody
Anti-Mitogen-Activated Protein Kinase 8-Interacting Protein 1 antibody
Anti-MAPK8IP1 antibody
Anti-IB1 antibody
Anti-JIP1 antibody
Anti-PRKM8IP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance